Aggressive Immunosuppression Minimization Shortens BK Viremia, Does Not Improve Outcome, but Increases the Risk of De Novo Donor Specific Antibodies in Kidney Recipients.

被引:0
|
作者
Devresse, A. [1 ,2 ]
Tinel, C. [1 ]
Vermorel, A. [1 ]
Snanoudj, R. [1 ]
Morin, L. [1 ]
Avettand-Fenoel, V. [3 ]
Amrouche, L. [1 ]
Scemla, A. [1 ]
Zuber, J. [1 ]
Legendre, C. [1 ]
Rabant, M. [4 ]
Anglicheau, D. [1 ]
机构
[1] Hop Necker Enfants Malad, Nephrol & Kidney Transplantat, Paris, France
[2] Univ Hosp St Luc, Nephrol, Brussels, Belgium
[3] Hop Necker Enfants Malad, Virol, Paris, France
[4] Hop Necker Enfants Malad, Pathol, Paris, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
136
引用
收藏
页码:299 / 299
页数:1
相关论文
共 50 条
  • [1] Development of de novo donor-specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction
    Hod-Dvorai, Reut
    Lee, Ryan
    Muluhngwi, Penn
    Raijmakers, Mariella
    Shetty, Aneesha
    Tambur, Anat R.
    Ison, Michael G.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [2] Kidney Transplant Recipients with De Novo Donor Specific Antibody is Associated with Increased Risk of Developing BK Viremia
    Kareem, S.
    Suresh, L.
    Gundroo, A.
    Von Viger, J.
    Chang, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 816 - 816
  • [3] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [4] Incidence of De Novo Donor Specific Antibodies After Early Steroid Withdrawal in Kidney Transplant Recipients.
    Majmundar, D.
    Karhadkar, S.
    Diamond, A.
    Au, J.
    Ruggia-Check, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 803 - 803
  • [5] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [6] DQ Molecules Are The Principal Stimulators of De Novo Donor Specific Antibodies in Non Sensitized Pediatric Kidney Recipients.
    Nocera, A.
    Tagliamacco, A.
    Cioni, M.
    Comoli, P.
    Cardillo, M.
    Fontana, I.
    Trivelli, A.
    Ramondetta, M.
    Magnasco, A.
    Biticchi, R.
    Ghiggeri, G.
    Garibotto, G.
    Ginevri, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 62 - 62
  • [7] BK Viremia (BKV) Persisting After Immunosuppression Reduction Does Not Increase Intermediate-Term Graft Loss But Is Associated With De Novo Donor Specific Antibodies (DSA).
    Sawinski, D.
    Forde, K.
    Trofe-Clark, J.
    Patel, P.
    Olivera, B.
    Goral, S.
    Bloom, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 84 - 85
  • [8] BK Viremia (BKV) Persisting After Immunosuppression Reduction Does Not Increase Intermediate-Term Graft Loss But Is Associated With De Novo Donor Specific Antibodies (DSA)
    Sawinski, D.
    Forde, K.
    Trofe-Clark, J.
    Patel, P.
    Olivera, B.
    Goral, S.
    Bloom, R.
    TRANSPLANTATION, 2014, 98 : 84 - 85
  • [9] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [10] Circulating De Novo Donor Specific Antibodies and Carotid Intima-Media Thickness in Pediatric Kidney Transplant Recipients.
    Sgambat, K.
    Clauss, S.
    Moudgil, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 974 - 975